Expression of the apoptosis-inducing FAS ligand (FASL) in human first and third trimester placenta and choriocarcinoma cells

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 3173-3175

  Bamberger, Ana Maria ^a   Schulte, Heinrich M ^a   Thuneke, Imke ^a   Erdmann, Insa ^a   Bamberger, Christoph M ^a   Asa, Sylvia L ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; TUMOR NECROSIS FACTOR;

ALLOGRAFT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHORIOCARCINOMA; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE STATUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE; PLACENTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIRD TRIMESTER PREGNANCY; TROPHOBLAST;

EID: 0030921819     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.9.4360     Document Type: Article

References (21)

1. Suda T, Takahashi T, Golstein P, Nagata S. 1993 Molecular cloning and expression of Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
2. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. 1995 Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
3. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. 1995 A role for CD95 ligand in preventing graft rejection. Nature. 377:630-632.
4. Hahne M, Rimoldi D, Schröter M, et al. 1996 Melanoma cell expression of Fas(Apo-1/CD95)ligand: implications for tumor immune escape. Science. 274:1363-1366.
5. Krammer PH, Dhein J, Walczak H, et al. 1994 The role of APO-1-mediated apoptosis in the immune system. Immunol Rev. 142:175-191.
6. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH. 1995 Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:438-441.
7. Ju S-T, Panka DJ, Cui H, et al. 1995 Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:444-448.
8. Nagata S. 1996 Fas ligand and immune evasion. Nature Medicine. 2:1306-1307.
9. Nagata S. 1997 Apoptosis by death factor. Cell. 88:355-365.
10. French LE, Hahne M, Viard I, et al. 1996 Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol. 133:335-343.
11. Strand S, Hofmann WJ, Hug H, et al. 1996 Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells-A mechanism of immune evasion? Nature Medicine. 2:1361-1366.
12. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. 1990 A class I antigen, HLA-G, expressed in human trophoblasts. Science. 248:220-223.
13. Hunt JS, Orr HT. 1992 HLA and maternal-fetal recognition. FASEB J. 6:2344-8.
14. Hunt JS. 1992 Immunobiology of pregnancy. Curr Op Immunol. 4:591-6.
15. Carosella ED, Dausset J, Kirszenbaum M. 1996 HLA-G revisited. Immunol Today. 7:407-409.
16. Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL. 1996 Protection from natural kliier cell-mediated lysis by HLA-G expression on target cells. Science. 274:792-795.
17. Chumbley G, King A, Robertson K, Holmes N, Loke YW. 1994 Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol. 155:312-322.
18. King A, Loke YW. 1993 Effect of IFN-g and IFN-a on killing of human trophoblast by decidual LAK cells. J Reprod Immunol. 23:51-62.
19. Saji F, Koyama M, Kameda T, Negoro T, Nakamuro K, Tanizawa O. 1987 Effect of a soluble factor secreted from cultured human trophoblast cells on in vitro lymphocyte reactions. Am J Reprod Immunol. 13:121-124.
20. Matsuzaki N, Okada T, Kameda T, Negoro T, Saji F, Tanizawa O. 1989 Analysis of site of action of a choriocarcinoma-derived immunomodulatory factor on IL-2-mediated T cell responses. J Reprod Immunol. 15:181-194.
21. Tanaka M, Suda T, Takahashi T, Nagata S. 1995 Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129-1135.